1
SARA, Smads and the internalization process. They found that loss of cPML destroys TGF-ȋ signalling, and began to dissect the molecular pathways that underpin the process. One sur- prise to come out of the work is that cPML is required for the interaction of Smads with SARA. This is puzzling because SARA can bind directly to Smads 7 , so why is cPML nec- essary for the interaction in vivo? Another remarkable result from the paper provides a clue: cPML also binds to TGF-ȋ receptors and is required for the movement of both the TGF- ȋ–receptor complex and SARA into the early endosome. One possible implication is that SARA can only bind to Smads inside the endo- some, and that one role of cPML is to bring the two together. These findings suggest that interference with receptor localization and SARA–Smad interactions is the main mecha- nism by which loss of cPML abrogates cellular responses to TGF-ȋ. The results raise lots of interesting ques- tions, an obvious one being: how does cPML regulate the localization of receptors and SARA to the early endosome? Does it pro- mote the transfer of the TGF-ȋ receptor into the endosome; does it regulate the time that the receptor complex stays in the endosome; or does it control the targeting of SARA to early endosomes? One hint at an answer comes from the observation that cPML has a RING-finger domain. In other cell-surface- located receptors, this domain mediates their trafficking by helping to attach a pro- tein tag called ubiquitin to them 8 . So, one function of cPML might be to promote the internalization of the receptors. The finding that cPML is required for TGF-ȋ signalling also converges nicely with observations that APL cell lines do not respond to TGF-ȋ 2 . APL is almost always linked with a rearrangement of the genes encoding PML and the retinoic-acid recep- tor-Ȋ (RARȊ). The outcome is a fusion involving one copy of the PML gene, which produces a PML–RARȊ fusion protein; this has aberrant activity 2 and inhibits the activity of the normal PML in these tumours. To wrap up their story,Lin et al. investiga- ted TGF-ȋ resistance in APL cell lines that contain the PML–RARȊ rearrangement. They confirmed that, in these cells, cPML– Smad complexes could not be detected and TGF-ȋ treatment does not promote Smad activation. By treating the cells with retinoic acid, which causes degradation of PML– RARȊ, the authors reversed this effect, con- firming that PML–RARȊ does indeed confer TGF-ȋ resistance by interfering with normal cPML still present in the cell. Thus, the work also touches on how the loss of functional cPML might contribute to the ‘antisocial’ behaviour of cancers that display resistance to TGF-ȋ. Moreover, it reveals a link between anomalies in trafficking events in the TGF-ȋ system and alterations in the signalling prop- erties of cancer cells. Christine Le Roy and Jeffrey L. Wrana are in the Department of Medical Genetics and Microbiology, University of Toronto, and the Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto M5G 1X5, Canada. e-mail: [email protected] 1. Siegel, P. M. & Massagué, J. Nature Rev. Cancer 3, 807–820 (2003). 2. Lin, H.-K., Bergmann, S. & Pandolfi, P. P. Nature 431, 205–211 (2004). 3. Salomoni, P. & Pandolfi, P. P. Cell 108, 165–170 (2002). 4. Attisano, L. & Wrana, J. L. Science 296, 1046–1047 (2002). 5. Di Guglielmo, G. M. et al. Nature Cell Biol. 5, 410–421 (2003). 6. Tsukazaki, T. et al. Cell 6, 779–791 (1998). 7. Wu, G. et al. Science 287, 92–97 (2000). 8. Marmor, M. D. & Yarden, Y. Oncogene 11, 2057–2070 (2004). news and views Cell biology An unexpected social servant Christine Le Roy and Jeffrey L. Wrana Cells communicate through signals that must be propagated from cell surface to nucleus. Tracking the signals generated by the transforming growth factor-ȋ protein reveals a surprising partner in this process. D uring the development and main- tenance of multicellular organisms, cells spend a lot of time communica- ting with each other to ensure that they are behaving in an appropriate and harmonious manner. This ‘social’ behaviour is mediated by the production of various signals outside the cell. These are interpreted in responding cells by networks of signal-transduction proteins that regulate the appropriate cellu- lar response. One major class of signals emitted by cells in all animals is the trans- forming growth factor-ȋ (TGF-ȋ) super- family of growth and differentiation factors, which control normal development and biological processes, as well as cancer pro- gression 1 . On page 205 of this issue, Lin and colleagues 2 report an unexpected participant in the network that interprets TGF-ȋ family signalling — cytoplasmic promyelocytic leukaemia protein (cPML). PML is involved in a range of biological functions that include cell ageing, cell prolif- eration and programmed cell death 3 . As its name suggests, when these functions are disrupted, the result is acute promyelocytic leukaemia (APL) — so PML is classed as a tumour-suppressor protein. Most tumour- suppressing activities of PML are ascribed to its nuclear functions, but the function of the cytoplasmic form (cPML) was a mystery. Now it seems that it is a key accessory protein in the transduction of TGF-ȋ signals. At the cell surface, TGF-ȋ interacts with two receptor complexes that function together to activate a downstream pathway of signalling proteins called Smads (Fig. 1). Smads move to the nucleus, where they can modulate cellular responses by regulating the expression of specific target genes 4 . One major feature of cell signalling is that recep- tors at the cell surface are transported into the cell, where they can either be recycled back to the cell surface, or be degraded. In the case of TGF-ȋ receptors, this internalization transfers some of the receptors into an organelle called the early endosome — a process that is crucial for TGF-ȋ signal transduction in some cells 5 . The importance of early endosomes in TGF-ȋ signalling is probably manifested by the presence of a protein called SARA (for ‘Smad anchor of receptor activation’) that can bind to both Smads and TGF-ȋ receptors 6 . Lin et al. 2 report that cPML is crucial in orchestrating the dance that goes on during a signalling event, coordinating the receptors, SARA SARA TβRII TβRI Plasma membrane cPML cPML cPML Smad2/3 Smad2/3 SARA cPML cPML Smad2/3 Smad2/3 TGF-β P a b c TGF-β signalling Early endosome TGF-β 142 NATURE | VOL 431 | 9 SEPTEMBER 2004 | www.nature.com/nature Figure 1 Transforming growth factor-ȋ (TGF-ȋ) signalling. Lin et al.’s work 2 suggests a role for the cytoplasmic form of promyelocytic leukaemia protein (cPML). At the cell surface, cPML might interact with the two TGF-ȋ receptors (TȋRI and TȋRII) and act as a bridging factor between SARA and Smad2/3. Upon stimulation with TGF- ȋ, cPML promotes the transfer of the complex containing TȋRI, TȋRII, SARA and Smad2 into early endosomes. There, cPML might dissociate from the complex (a), allowing Smad2/3 to interact with SARA (b) and to be phosphorylated (c) by TȋRI. Phosphorylated Smad2/3 moves into the nucleus to propagate TGF-ȋ signalling. ©2004 Nature Publishing Group

Cell biology: An unexpected social servant

Embed Size (px)

Citation preview

Page 1: Cell biology: An unexpected social servant

SARA, Smads and the internalization process.They found that loss of cPML destroys TGF-�signalling, and began to dissect the molecularpathways that underpin the process. One sur-prise to come out of the work is that cPML isrequired for the interaction of Smads withSARA. This is puzzling because SARA canbind directly to Smads7, so why is cPML nec-essary for the interaction in vivo? Anotherremarkable result from the paper provides aclue: cPML also binds to TGF-� receptors andis required for the movement of both the TGF-�–receptor complex and SARA into the earlyendosome. One possible implication is that

SARA can only bind to Smads inside the endo-some, and that one role of cPML is to bring the two together. These findings suggest thatinterference with receptor localization andSARA–Smad interactions is the main mecha-nism by which loss of cPML abrogates cellularresponses to TGF-�.

The results raise lots of interesting ques-tions, an obvious one being: how does cPMLregulate the localization of receptors andSARA to the early endosome? Does it pro-mote the transfer of the TGF-� receptor intothe endosome; does it regulate the time thatthe receptor complex stays in the endosome;or does it control the targeting of SARA toearly endosomes? One hint at an answercomes from the observation that cPML has aRING-finger domain. In other cell-surface-located receptors, this domain mediatestheir trafficking by helping to attach a pro-tein tag called ubiquitin to them8. So, onefunction of cPML might be to promote theinternalization of the receptors.

The finding that cPML is required forTGF-� signalling also converges nicely withobservations that APL cell lines do notrespond to TGF-�2. APL is almost alwayslinked with a rearrangement of the genesencoding PML and the retinoic-acid recep-tor-� (RAR�). The outcome is a fusioninvolving one copy of the PML gene, whichproduces a PML–RAR� fusion protein; thishas aberrant activity2 and inhibits the activityof the normal PML in these tumours.

To wrap up their story, Lin et al. investiga-ted TGF-� resistance in APL cell lines thatcontain the PML–RAR� rearrangement.They confirmed that, in these cells, cPML–Smad complexes could not be detected andTGF-� treatment does not promote Smadactivation. By treating the cells with retinoicacid, which causes degradation of PML–RAR�, the authors reversed this effect, con-firming that PML–RAR� does indeed conferTGF-� resistance by interfering with normalcPML still present in the cell. Thus, the workalso touches on how the loss of functionalcPML might contribute to the ‘antisocial’behaviour of cancers that display resistanceto TGF-�. Moreover, it reveals a link betweenanomalies in trafficking events in the TGF-�system and alterations in the signalling prop-erties of cancer cells. ■

Christine Le Roy and Jeffrey L. Wrana are in theDepartment of Medical Genetics and Microbiology,University of Toronto, and the Program inMolecular Biology and Cancer, Samuel LunenfeldResearch Institute, Mount Sinai Hospital,600 University Avenue, Toronto M5G 1X5, Canada.e-mail: [email protected]. Siegel, P. M. & Massagué, J. Nature Rev. Cancer 3, 807–820 (2003).2. Lin, H.-K., Bergmann, S. & Pandolfi, P. P. Nature 431, 205–211

(2004).3. Salomoni, P. & Pandolfi, P. P. Cell 108, 165–170 (2002).4. Attisano, L. & Wrana, J. L. Science 296, 1046–1047 (2002).5. Di Guglielmo, G. M. et al. Nature Cell Biol. 5, 410–421 (2003).6. Tsukazaki, T. et al. Cell 6, 779–791 (1998).7. Wu, G. et al. Science 287, 92–97 (2000).8. Marmor, M. D. & Yarden, Y. Oncogene 11, 2057–2070 (2004).

news and views

Cell biology

An unexpected social servantChristine Le Roy and Jeffrey L. Wrana

Cells communicate through signals that must be propagated from cellsurface to nucleus. Tracking the signals generated by the transforminggrowth factor-� protein reveals a surprising partner in this process.

During the development and main-tenance of multicellular organisms,cells spend a lot of time communica-

ting with each other to ensure that they arebehaving in an appropriate and harmoniousmanner. This ‘social’ behaviour is mediatedby the production of various signals outsidethe cell. These are interpreted in respondingcells by networks of signal-transductionproteins that regulate the appropriate cellu-lar response. One major class of signalsemitted by cells in all animals is the trans-forming growth factor-� (TGF-�) super-family of growth and differentiation factors,which control normal development and biological processes, as well as cancer pro-gression1. On page 205 of this issue, Lin andcolleagues2 report an unexpected participantin the network that interprets TGF-� familysignalling — cytoplasmic promyelocyticleukaemia protein (cPML).

PML is involved in a range of biologicalfunctions that include cell ageing, cell prolif-eration and programmed cell death3. As itsname suggests, when these functions are disrupted, the result is acute promyelocyticleukaemia (APL) — so PML is classed as atumour-suppressor protein. Most tumour-suppressing activities of PML are ascribed toits nuclear functions, but the function of thecytoplasmic form (cPML) was a mystery.Now it seems that it is a key accessory proteinin the transduction of TGF-� signals.

At the cell surface, TGF-� interacts withtwo receptor complexes that functiontogether to activate a downstream pathwayof signalling proteins called Smads (Fig. 1).Smads move to the nucleus, where they canmodulate cellular responses by regulatingthe expression of specific target genes4. Onemajor feature of cell signalling is that recep-tors at the cell surface are transported intothe cell, where they can either be recycledback to the cell surface,or be degraded.In thecase of TGF-� receptors, this internalizationtransfers some of the receptors into anorganelle called the early endosome — a process that is crucial for TGF-� signaltransduction in some cells5. The importanceof early endosomes in TGF-� signalling isprobably manifested by the presence of aprotein called SARA (for ‘Smad anchor ofreceptor activation’) that can bind to bothSmads and TGF-� receptors6.

Lin et al.2 report that cPML is crucial inorchestrating the dance that goes on during asignalling event, coordinating the receptors,

SARASARA

TβRII TβRI

Plasmamembrane

cPML

cPML

cPMLSmad2/3Smad2/3

SARA

cPML

cPML

Smad2/3

Smad2/3

TGF-β

P

a

b

c

TGF-β signalling

Early endosome

TGF-β

142 NATURE | VOL 431 | 9 SEPTEMBER 2004 | www.nature.com/nature

Figure 1 Transforming growth factor-� (TGF-�)signalling. Lin et al.’s work2 suggests a role for thecytoplasmic form of promyelocytic leukaemiaprotein (cPML). At the cell surface, cPML mightinteract with the two TGF-� receptors (T�RI and T�RII) and act as a bridging factor betweenSARA and Smad2/3. Upon stimulation with TGF-�, cPML promotes the transfer of the complexcontaining T�RI, T�RII, SARA and Smad2 intoearly endosomes. There, cPML might dissociatefrom the complex (a), allowing Smad2/3 tointeract with SARA (b) and to be phosphorylated(c) by T�RI. Phosphorylated Smad2/3 moves intothe nucleus to propagate TGF-� signalling.

9.9 n&v 133 MH 3/9/04 5:29 pm Page 142

© 2004 Nature Publishing Group